Does the Choice of Administration Sequence of Propofol and Remifentanil Affect the ED50 and ED95 of Rocuronium for Rapid Sequence Induction of Anesthesia?

Trial Profile

Does the Choice of Administration Sequence of Propofol and Remifentanil Affect the ED50 and ED95 of Rocuronium for Rapid Sequence Induction of Anesthesia?

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Rocuronium bromide (Primary) ; Propofol; Remifentanil
  • Indications Anaesthesia
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Jul 2016 Status changed from recruiting to completed.
    • 18 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top